An update on the management of acute esophageal variceal bleeding

Bosch, 2005, Documento de Consenso: Hipertensi¢n Portal, Gastroenterol Hepatol, 28, 1 Bosch, 2012, [Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases(CIBERehd)], Gastroenterol Hepatol, 35, 421, 10.1016/j.gastrohep.2012.02.009 Graham, 1981, The course of patients after variceal hemorrhage, Gastroenterology, 80, 800, 10.1016/0016-5085(81)90144-X D’Amico, 2003, Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators, Hepatology, 38, 599, 10.1053/jhep.2003.50385 Reverter, 2014, A MELD-based model to determine risk of mortality among patients with acute variceal bleeding, Gastroenterology, 146, 412, 10.1053/j.gastro.2013.10.018 Abraldes, 2007, The treatment of acute variceal bleeding, J Clin Gastroenterol, 41, S312, 10.1097/MCG.0b013e318150d3dd Mayorga, 2013, Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis, Clin Gastroenterol Hepatol, 11, 1342, 10.1016/j.cgh.2013.04.021 de Franchis, 2010, Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 53, 762, 10.1016/j.jhep.2010.06.004 Villanueva, 2013, Transfusion strategies for acute upper gastrointestinal bleeding, N Engl J Med, 368, 11, 10.1056/NEJMoa1211801 Bosch, 2004, Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial, Gastroenterology, 127, 1123, 10.1053/j.gastro.2004.07.015 Bosch, 2008, Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial, Hepatology, 47, 1604, 10.1002/hep.22216 Bendtsen, 2014, Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials, J Hepatol, 61, 252, 10.1016/j.jhep.2014.03.035 Chavez-Tapia, 2010, Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding, Cochrane Database Syst Rev, CD002907 Fernandez, 2012, Management of bacterial infections in cirrhosis, J Hepatol, 56, S1, 10.1016/S0168-8278(12)60002-6 Bernard, 1999, Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis, Hepatology, 29, 1655, 10.1002/hep.510290608 Pauwels, 1996, Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection, Hepatology, 24, 802 Jalan, 2014, Bacterial infections in cirrhosis. a position statement based on the EASL Special Conference 2013, J Hepatol, 60, 1310, 10.1016/j.jhep.2014.01.024 Goulis, 1998, Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage, Hepatology, 27, 1207, 10.1002/hep.510270504 Hou, 2004, Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial, Hepatology, 39, 746, 10.1002/hep.20126 Soares-Weiser, 2001, Antibiotics for spontaneous bacterial peritonitis in cirrhotics, Cochrane Database Syst Rev, 3, CD002232 Garcia-Tsao, 2010, Management of varices and variceal hemorrhage in cirrhosis, N Engl J Med, 362, 823, 10.1056/NEJMra0901512 Carbonell, 2004, Improved survival after variceal bleeding in patients with cirrhosis over the past two decades, Hepatology, 40, 652, 10.1002/hep.20339 Tandon, 2015, Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics, Clin Gastroenterol Hepatol, 13, 1189, 10.1016/j.cgh.2014.11.019 de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Fernandez, 2012, Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study, Hepatology, 55, 1551, 10.1002/hep.25532 Vilstrup, 2014, Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver, Hepatology, 60, 715, 10.1002/hep.27210 Sharma, 2011, Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose, J Gastroenterol Hepatol, 26, 996, 10.1111/j.1440-1746.2010.06596.x Maharshi, 2015, Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed, Gut, 64, 1341, 10.1136/gutjnl-2014-308521 Cardenas, 2001, Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis, Hepatology, 34, 671, 10.1053/jhep.2001.27830 Angeli, 2015, Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites, Gut., 64, 531, 10.1136/gutjnl-2014-308874 Banares, 2002, Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis, Hepatology, 35, 609, 10.1053/jhep.2002.31354 Cales, 2001, Early administration of vapreotide for variceal bleeding in patients with cirrhosis, N Engl J Med, 344, 23, 10.1056/NEJM200101043440104 Lo, 2009, Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices, Gut, 58, 1275, 10.1136/gut.2008.165910 Wells, 2012, Meta-analysis: vasoactive medications for the management of acute variceal bleeds, Aliment Pharmacol Ther, 35, 1267, 10.1111/j.1365-2036.2012.05088.x Seo, 2014, Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage, Hepatology, 60, 954, 10.1002/hep.27006 Sola, 2010, Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension, Hepatology, 52, 1783, 10.1002/hep.23893 Garcia-Tsao, 2008, Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver Single-Topic Conference, Hepatology, 47, 1764, 10.1002/hep.22273 Azam, 2012, Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial, J Hepatol, 56, 819, 10.1016/j.jhep.2011.11.019 Bai, 2011, Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding, Aliment Pharmacol Ther, 34, 166, 10.1111/j.1365-2036.2011.04708.x Villanueva, 2006, A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding, J Hepatol, 45, 560, 10.1016/j.jhep.2006.05.016 Avgerinos, 2004, Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis, Hepatology, 39, 1623, 10.1002/hep.20236 Garcia-Tsao, 2007, Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis, Am J Gastroenterol, 102, 2086, 10.1111/j.1572-0241.2007.01481.x Bosch, 2003, Current management of portal hypertension, J Hepatol, 38, S54, 10.1016/S0168-8278(02)00430-0 Hubmann, 2006, The use of self-expanding metal stents to treat acute esophageal variceal bleeding, Endoscopy, 38, 896, 10.1055/s-2006-944662 Wright, 2010, A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center, Gastrointest Endosc, 71, 71, 10.1016/j.gie.2009.07.028 Marot, 2015, Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding, Aliment Pharmacol Ther, 42, 1250, 10.1111/apt.13424 Escorsell, 2015, Esophageal balloon tamponade vs esophageal stent in controlling acute refractory variceal bleeding: a multicenter RCT, Hepatology Bosch, 2001, Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?, J Hepatol, 35, 658, 10.1016/S0168-8278(01)00238-0 Monescillo, 2004, Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding, Hepatology, 40, 793, 10.1002/hep.20386 Garcia-Pagan, 2010, Early use of TIPS in patients with cirrhosis and variceal bleeding, N Engl J Med, 362, 2370, 10.1056/NEJMoa0910102 Garcia-Pagan, 2013, Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study, J Hepatol, 58, 45, 10.1016/j.jhep.2012.08.020 Rudler, 2014, Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival, Aliment Pharmacol Ther, 40, 1074, 10.1111/apt.12934 Kjaergard, 1999, Randomized clinical trials in HEPATOLOGY: predictors of quality, Hepatology, 30, 1134, 10.1002/hep.510300510 Burroughs, 2001, Assessment of value of consensus definitions in acute variceal bleeding, Lancet, 357, 1147, 10.1016/S0140-6736(00)04383-X Abraldes, 2015, Soft and hard endpoints in acute variceal bleeding, Hepatology, 61, 762, 10.1002/hep.27583 Meeting Report from FDA Gastrointestinal Drugs Advisory Committee. 2009-05-19 Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM191908.pdf